NEW YORK (GenomeWeb) – Reaction Biology said today it has received a Small Business Innovation Research grant from the National Center for Advancing Translational Sciences to create a database of epigenetic drug interactions.

The Malvern, Pa.-based company said it will use the $288,000 grant to study the interactions of more than 1,400 drugs and drug-like compounds that have been approved by the US Food and Drug Administration.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Rare gene mutations are guiding the search for drugs to manage chronic pain without opioids, according to CNBC.

The new Francis Crick Institute building can get too noisy for some researchers to concentrate, according to the Guardian.

CBS News reports that there are still many vacancies at the White House Office of Science and Technology Policy, but that it's uncertain whether they will be filled.

In Nucleic Acids Research this week: pipeline to analyze and visualize bacterial genomes, database of global set of human genomes, and more.